Evidence map›Paper›PMID 29947927›Full record

ReviewCellular and molecular life sciences : CMLS2018

Mechanisms of protein toxicity in neurodegenerative diseases.

Chang Geon Chung, Hyosang Lee, Sung Bae Lee

Abstract readReview
In one paragraph

Review in Cellular and molecular life sciences : CMLS, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 78 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
78citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

78 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Review
  14. Imaging methods to monitor and quantify cell differentiation.Frontiers in cell and developmental biology · 2025
    Review
  15. Roles of C/EBPβ/AEP in Neurodegenerative Diseases.Current topics in medicinal chemistry · 2025
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

18 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Chang Geon ChungDepartment of Brain and Cognitive Sciences, DGIST, Daegu, 42988, Republic of Korea.
Hyosang LeeDepartment of Brain and Cognitive Sciences, DGIST, Daegu, 42988, Republic of Korea. hyosang22@dgist.ac.kr.
Sung Bae LeeDepartment of Brain and Cognitive Sciences, DGIST, Daegu, 42988, Republic of Korea. sblee@dgist.ac.kr.ORCID http://orcid.org/0000-0002-8980-6769

Funding

Korea Research Institute of Standards and Science KRISS-2018-GP2018-0018Ministry of Science and ICT 18-01-HRSS-02Ministry of Science and ICT 18-BD-0402Ministry of Science and ICT 18-BR-04-03Ministry of Science and ICT 18-BT-02Ministry of Science, ICT and Future Planning 2016M3C7A1904148Ministry of Science, ICT and Future Planning 2016M3C7A1947307Ministry of Science, ICT and Future Planning 2017R1A2B4003351
6 · The paper itself

Abstract

Protein toxicity can be defined as all the pathological changes that ensue from accumulation, mis-localization, and/or multimerization of disease-specific proteins. Most neurodegenerative diseases manifest protein toxicity as one of their key pathogenic mechanisms, the details of which remain unclear. By systematically deconstructing the nature of toxic proteins, we aim to elucidate and illuminate some of the key mechanisms of protein toxicity from which therapeutic insights may be drawn. In this review, we focus specifically on protein toxicity from the point of view of various cellular compartments such as the nucleus and the mitochondria. We also discuss the cell-to-cell propagation of toxic disease proteins that complicates the mechanistic understanding of the disease progression as well as the spatiotemporal point at which to therapeutically intervene. Finally, we discuss selective neuronal vulnerability, which still remains largely enigmatic.

Indexed as

AnimalsCell NucleusDisease ProgressionHumansMitochondriaNeurodegenerative DiseasesNeuronsProteinsProteinsAlzheimer’s diseaseAmyotrophic lateral sclerosisFrontotemporal dementiaHuntington’s diseaseLou Gehrig’s diseaseParkinson’s diseasePolyglutamine diseasesProtein inclusionsStress granules

Identifiers

PMID29947927
PMCPMC6063327

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.